Bintao Hu

497 total citations
22 papers, 317 citations indexed

About

Bintao Hu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bintao Hu has authored 22 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Bintao Hu's work include Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Bintao Hu is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (5 papers). Bintao Hu collaborates with scholars based in China. Bintao Hu's co-authors include Yajun Ruan, Jihong Liu, Xiaming Liu, Yang Luan, Huan Feng, Zhuo Liu, Tao Wang, Shaogang Wang, Tao Wang and Wei Xian and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Bintao Hu

20 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bintao Hu China 11 126 94 94 75 63 22 317
C. Roemer-Bécuwe France 8 88 0.7× 105 1.1× 152 1.6× 63 0.8× 19 0.3× 15 346
Nina R. Shah United States 8 224 1.8× 74 0.8× 231 2.5× 34 0.5× 51 0.8× 17 471
Fufan Zhu China 13 172 1.4× 209 2.2× 55 0.6× 30 0.4× 121 1.9× 22 578
Soyoun Rachel Kim Canada 10 226 1.8× 29 0.3× 45 0.5× 37 0.5× 43 0.7× 32 345
Martin Koch Germany 8 49 0.4× 64 0.7× 61 0.6× 23 0.3× 41 0.7× 18 254
Alexis Trécourt France 10 78 0.6× 27 0.3× 68 0.7× 30 0.4× 18 0.3× 34 225
Michele Paudice Italy 9 91 0.7× 34 0.4× 71 0.8× 28 0.4× 33 0.5× 47 246
Amy L. Gross United States 10 152 1.2× 102 1.1× 154 1.6× 39 0.5× 81 1.3× 14 538
Xiyi Jiang China 11 46 0.4× 135 1.4× 152 1.6× 63 0.8× 118 1.9× 26 415
Mae Zakhour United States 6 80 0.6× 46 0.5× 56 0.6× 15 0.2× 35 0.6× 17 237

Countries citing papers authored by Bintao Hu

Since Specialization
Citations

This map shows the geographic impact of Bintao Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bintao Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bintao Hu more than expected).

Fields of papers citing papers by Bintao Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bintao Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bintao Hu. The network helps show where Bintao Hu may publish in the future.

Co-authorship network of co-authors of Bintao Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Bintao Hu. A scholar is included among the top collaborators of Bintao Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bintao Hu. Bintao Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Chenglin, Bin Yang, Bintao Hu, et al.. (2025). Atractylenolide I ameliorated the growth and enzalutamide resistance of castration-resistant prostate cancer by targeting KIF15. Chinese Medicine. 20(1). 35–35. 1 indexed citations
2.
Zhang, Sicheng, Qian Ma, Yuqiu Zhou, et al.. (2025). AI-assisted precise identification and segmentation of parathyroid glands in multi-approach endoscopic and robotic thyroid surgeries. European Journal of Surgical Oncology. 51(12). 110506–110506.
3.
Hu, Bintao, et al.. (2025). RNA Binding Motif Protein 15 (RBM15): Structure, Function and Its Research Progress in Tumors. International Journal of General Medicine. Volume 18. 3635–3649.
4.
Hu, Bintao, Dongxu Lin, Ruibao Chen, et al.. (2024). Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs. European journal of medical research. 29(1). 411–411. 2 indexed citations
5.
Hu, Bintao, Chengwei Wang, Chenglin Han, et al.. (2024). Revealing the mechanism of ethyl acetate extracts of Semen Impatientis against prostate cancer based on network pharmacology and transcriptomics. Journal of Ethnopharmacology. 330. 118228–118228. 4 indexed citations
6.
Wang, Chengwei, Xi Zhang, Bintao Hu, et al.. (2024). Prediction of clear cell renal cell carcinoma prognosis based on an immunogenomic landscape analysis. Heliyon. 10(16). e36156–e36156. 1 indexed citations
7.
8.
Liu, Yuhong, et al.. (2023). Stimulating effects of submerged plants on removing of N from the water in the Daihai lake of inner Mongolia autonomous region, China. Frontiers in Environmental Science. 11. 5 indexed citations
9.
Lin, Dongxu, et al.. (2023). Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma. Frontiers in Oncology. 13. 10 indexed citations
10.
Han, Chenglin, Bin Yang, Peng Hu, et al.. (2023). Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer. Frontiers in Immunology. 14. 1126902–1126902. 5 indexed citations
11.
Hu, Bintao, Kang Liu, Yajun Ruan, et al.. (2022). Evaluation of mid- and long-term impact of COVID-19 on male fertility through evaluating semen parameters. Translational Andrology and Urology. 11(2). 159–167. 28 indexed citations
12.
Wu, Yue, Xi Zhang, Wei Xian, et al.. (2021). A Mitochondrial Dysfunction and Oxidative Stress Pathway‐Based Prognostic Signature for Clear Cell Renal Cell Carcinoma. Oxidative Medicine and Cellular Longevity. 2021(1). 9939331–9939331. 30 indexed citations
13.
Wu, Yue, Xi Zhang, Wei Xian, et al.. (2021). Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma. Frontiers in Cell and Developmental Biology. 9. 684643–684643. 11 indexed citations
14.
Hu, Bintao, Yajun Ruan, Kang Liu, et al.. (2021). A Mid-to-Long Term Comprehensive Evaluation of Psychological Distress and Erectile Function in COVID-19 Recovered Patients. The Journal of Sexual Medicine. 18(11). 1863–1871. 16 indexed citations
15.
Wu, Yue, Wei Xian, Huan Feng, et al.. (2021). Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma. Frontiers in Genetics. 11. 617872–617872. 11 indexed citations
16.
Wu, Yue, Wei Xian, Huan Feng, et al.. (2021). Integrated Analysis to Identify a Redox‐Related Prognostic Signature for Clear Cell Renal Cell Carcinoma. Oxidative Medicine and Cellular Longevity. 2021(1). 6648093–6648093. 19 indexed citations
17.
Wu, Yue, Xi Zhang, Huan Feng, et al.. (2021). Exploration of Redox‐Related Molecular Patterns and the Redox Score for Prostate Cancer. Oxidative Medicine and Cellular Longevity. 2021(1). 4548594–4548594. 5 indexed citations
18.
Wu, Yue, Zheng Liu, Wei Xian, et al.. (2021). Identification of the Functions and Prognostic Values of RNA Binding Proteins in Bladder Cancer. Frontiers in Genetics. 12. 574196–574196. 21 indexed citations
19.
Wu, Yue, Wei Xian, Huan Feng, et al.. (2020). An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma. Aging. 12(22). 23165–23186. 15 indexed citations
20.
Feng, Huan, Wei Xian, Yue Wu, et al.. (2020). Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer. Frontiers in Molecular Biosciences. 7. 189–189. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Roemer-Bécuwe Breakdown of academic impact, for papers by Nina R. Shah Breakdown of academic impact, for papers by Fufan Zhu Breakdown of academic impact, for papers by Soyoun Rachel Kim Breakdown of academic impact, for papers by Martin Koch Breakdown of academic impact, for papers by Alexis Trécourt Breakdown of academic impact, for papers by Michele Paudice Breakdown of academic impact, for papers by Amy L. Gross Breakdown of academic impact, for papers by Xiyi Jiang Breakdown of academic impact, for papers by Mae Zakhour
Rankless by CCL
2026